Global expansion KUR Research is expanding internationally with Chennai, India operations and a recent leadership hire as President and Chief Commercial Officer, signaling readiness to pursue cross-border clinical trials and partner programs in emerging markets.

Clinical scale With over a decade of experience and hundreds of trials, including 100+ medical device and diagnostic studies and 10,000+ volunteers with high retention, KUR demonstrates capacity to handle large enrollment targets and complex study protocols.

Private practice network KUR partners with community-based private practices, urgent cares, and specialists, enabling rapid site access to diverse populations which can streamline patient recruitment and broaden trial demographics for sponsors.

Leadership traction Recent appointment of John Giammona as President and Chief Commercial Officer indicates a strategic push in commercial growth, partnerships, and scalable sales initiatives.

Technology stack Utilizes established tools like Medrio for eSource/eCRF, analytics and tagging platforms, and common web/marketing tech, suggesting opportunities to upsell advanced data capture, real-time analytics, and streamlined study management capabilities.